描述:LY 311727 is a specific group II sPLA2 (phospholipase A2 (PLA2)) inhibitor which has been reported to attenuate VEGF-mediated platelet-activating factor (PAF) synthesis in HUVEC and BAEC cells.
应用:A specific PLA2 inhibitor reported to attenuate VEGF-mediated platelet-activating factor synthesis